Thomas Jefferson University

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Yeo, Charles
One or more keywords matched the following items that are connected to Yeo, Charles
Item TypeName
Concept Antimetabolites, Antineoplastic
Academic Article Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma.
Academic Article One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.
Academic Article pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.
Academic Article The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma.
Academic Article The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer.
Academic Article Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
Academic Article Role of adjuvant therapy in the management of pancreatic cancer.
Academic Article Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival.
Academic Article Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
Academic Article Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
Academic Article Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil. Is it time to move forward?
Academic Article Limits to thymidylate synthase and TP53 genes as predictive determinants for fluoropyrimidine sensitivity and further evidence for RNA-based toxicity as a major influence.
Academic Article The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.
Search Criteria
  • Antimetabolites Antineoplastic